article_metadata: Xukai Luo Yating Sun Jiajia Li Qidi Jiang Lei Yuan Ting Li Mo Chen Liangqing Yao
article_metadata: 10.3389/fimmu.2022.951422
article_metadata: Front Immunol
article_metadata: 2022 Oct 6;13:951422.
article_metadata: hla-b44 supertype pd-l1 chemotherapy resistant immunotherapy ovarian clear cell carcinoma platinum resistance recurrence
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36275748/
article_metadata: Antineoplastic Agents, Immunological / therapeutic use Ovarian Neoplasms / drug therapy Ovarian Neoplasms / genetics
article_metadata: Antineoplastic Agents, Immunological / therapeutic use Ovarian Neoplasms / drug therapy Ovarian Neoplasms / genetics Case Reports Research Support, Non-U.S. Gov't Apoptosis B7-H1 Antigen / metabolism Carcinoma, Ovarian Epithelial Female HLA-B44 Antigen Humans Immune Checkpoint Inhibitors Neoplasm Recurrence, Local / drug therapy Platinum Programmed Cell Death 1 Receptor / metabolism B7-H1 Antigen Programmed Cell Death 1 Receptor HLA-B44 Antigen Antineoplastic Agents, Immunological Immune Checkpoint Inhibitors Platinum
article_metadata: PMC9582938
article_metadata: 36275748
article_metadata: A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report
article_metadata: 2022